Xiujun Liu

Statistics

Publications

Citations

865

H-Index

Active since

2010

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

First Affiliated Hospital of Zhengzhou University

Zhengzhou University

North China University of Science and Technology

Qingdao University

Xiujun Liu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

2010–2023

Publications

SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1

Na Zhang, Yueying Dou, Lu Liu et al. · EBioMedicine · 2019 · 74 citations · Full text

Life Sciences, Immunology, Oncology +17

The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Jiajia Shen, Pengyu Li, Xuejing Shao et al. · Cancer Research · 2017 · 65 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives

Xuedong Jia, Shuo Wang, Minghua Wang et al. · Chinese Chemical Letters · 2016 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Stereo‐ and Regioselective Phyllobilane Oxidation in Leaf Homogenates of the Peace Lily (<i>Spathiphyllum wallisii)</i>: Hypothetical Endogenous Path to Yellow Chlorophyll Catabolites

Clemens Vergeiner, Markus Ulrich, Chengjie Li et al. · Chemistry - A European Journal · 2014 · 40 citations · Full text

Life Sciences, Biochemistry, Plant Sciences +12

An <scp>EGFR</scp>‐targeting antibody–drug conjugate <scp>LR</scp>004‐<scp>VC</scp>‐<scp>MMAE</scp>: potential in esophageal squamous cell carcinoma and other malignancies

Xinyue Hu, Rong Wang, Jie Jin et al. · Molecular Oncology · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 33